PUBLISHER: BIS Research | PRODUCT CODE: 1501635
PUBLISHER: BIS Research | PRODUCT CODE: 1501635
Europe Highly Potent API Market - Analysis and Forecast, 2023-2033
Introduction to Europe Highly Potent API Market
The Europe highly potent API market is projected to reach $16.33 billion by 2033 from $5.98 billion in 2023, growing at a CAGR of 10.57% during the forecast period 2023-2033. The primary factors propelling the expansion of the highly potent API market are the rising incidence of cancer, which boosts the demand for highly potent APIs, and the broadening range of therapeutic applications for these APIs.
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2023 - 2033 |
| 2023 Evaluation | $5.98 Billion |
| 2033 Forecast | $16.33 Billion |
| CAGR | 10.57% |
Market Introduction
The Europe Highly Potent API market is experiencing significant growth, driven by increasing cancer prevalence and the expanding application of HPAPIs in various therapeutic areas. The region's robust pharmaceutical industry, supported by advanced R&D facilities and stringent regulatory frameworks, enhances market development. Key players in Europe are investing heavily in manufacturing capabilities and collaborative partnerships to meet the rising demand. Additionally, the adoption of innovative technologies and processes ensures the production of high-quality, safe HPAPIs. The market is further fueled by the growing outsourcing trend to specialized contract manufacturing organizations (CMOs) with expertise in handling highly potent compounds, ensuring compliance with safety and environmental regulations, and reducing operational costs for pharmaceutical companies.
Market Segmentation:
Segmentation 1: by Country
- U.K.
- Germany
- France
- Italy
- Spain
- Rest-of-Europe
How can this report add value to an organization?
Competitive Strategy: The highly potent API market has numerous established players with product and service portfolios. Key players in the Europe highly potent API market analysed and profiled in the study involve established players offering products and services of highly potent API.
Key Market Players and Competition Synopsis
The companies that are profiled have been selected based on inputs gathered from primary experts and analysing company coverage, type portfolio, and market penetration.
Some prominent names in the market include:
- Almac Group
- Axplora Group GmbH
- BASF Pharma Solutions
- CordenPharma International
- Helsinn Healthcare SA.
- ICROM
- Lonza
- Merck KGaA
- Sterling Pharma Solutions
Table of Contents
Executive Summary
Scope and Definition
1 Markets
- 1.1 Trends: Current and Future Impact Assessment
- 1.1.1 Trend 1: Advancements in Containment Technologies for Highly Potent APIs
- 1.1.2 Trend 2: Increasing Investment for Highly Potent API Manufacturing Units
- 1.1.3 Trend 3: Pharmaceutical Companies Outsourcing Highly Potent APIs Production to CDMOs
- 1.2 Supply Chain /Value Overview
- 1.2.1 Supply Chain and Risks within the Supply Chain
- 1.2.2 Value Chain Analysis
- 1.3 Pricing Analysis
- 1.4 Patent Filing Trend (by Year, Country)
- 1.5 Regulatory Landscape
- 1.6 Impact Analysis for Key Global Events - COVID-19
- 1.7 Market Dynamics: Overview
- 1.7.1 Market Drivers
- 1.7.1.1 Increasing Incidence of Cancer Leading to Demand in the Adoption of Highly Potent APIs
- 1.7.1.2 Advancements in Drug Delivery Technologies
- 1.7.1.3 Expanding Therapeutic Applications of Highly Potent API
- 1.7.2 Market Opportunities
- 1.7.2.1 Growing Emphasis on Personalized Medicine
- 1.7.2.2 Increasing Opportunities for Pharma Companies in Developing Markets
- 1.7.3 Market Restraints
- 1.7.3.1 Regulatory Complexity for Highly Potent APIs' Manufacturing
- 1.7.3.2 High Development and Production Costs
- 1.7.1 Market Drivers
2 Regions
- 2.1 Regional Summary
- 2.2 Europe
- 2.2.1 Regional Overview
- 2.2.2 Driving Factors for Market Growth
- 2.2.3 Factors Challenging the Market
- 2.2.4 France
- 2.2.5 Germany
- 2.2.6 U.K.
- 2.2.7 Spain
- 2.2.8 Italy
- 2.2.9 Rest-of-Europe
3 Markets -Competitive Benchmarking & Company Profiles
- 3.1 Next Frontiers
- 3.2 Geographic Assessment
- 3.2.1 Almac Group
- 3.2.1.1 Overview
- 3.2.1.2 Key Developments
- 3.2.1.3 Top Products/Product/Service Portfolio
- 3.2.1.4 Top Competitors
- 3.2.1.5 Key Personnel
- 3.2.1.6 Analyst View
- 3.2.2 Axplora Group GmbH
- 3.2.2.1 Overview
- 3.2.2.2 Top Products/Product/Service Portfolio
- 3.2.2.3 Key Developments
- 3.2.2.4 Top Competitors
- 3.2.2.5 Key Personnel
- 3.2.2.6 Analyst View
- 3.2.3 BASF SE
- 3.2.3.1 Overview
- 3.2.3.2 Top Products/Product/Service Portfolio
- 3.2.3.3 Key Developments
- 3.2.3.4 Top Competitors
- 3.2.3.5 Key Personnel
- 3.2.3.6 Analyst View
- 3.2.4 CordenPharma International
- 3.2.4.1 Overview
- 3.2.4.2 Top Products/Product/Service Portfolio
- 3.2.4.3 Key Developments
- 3.2.4.4 Top Competitors
- 3.2.4.5 Key Personnel
- 3.2.4.6 Analyst View
- 3.2.5 Helsinn Healthcare SA.
- 3.2.5.1 Overview
- 3.2.5.2 Top Products/Product/Service Portfolio
- 3.2.5.3 Key Developments
- 3.2.5.4 Top Competitors
- 3.2.5.5 Key Personnel
- 3.2.5.6 Analyst View
- 3.2.6 ICROM
- 3.2.6.1 Overview
- 3.2.6.2 Top Products/Product/Service Portfolio
- 3.2.6.3 Top Competitors
- 3.2.6.4 Key Personnel
- 3.2.6.5 Analyst View
- 3.2.7 Lonza
- 3.2.7.1 Overview
- 3.2.7.2 Top Products/Product/Service Portfolio
- 3.2.7.3 Key Developments
- 3.2.7.4 Top Competitors
- 3.2.7.5 Key Personnel
- 3.2.7.6 Analyst View
- 3.2.8 Merck KGaA
- 3.2.8.1 Overview
- 3.2.8.2 Top Products/Product/Service Portfolio
- 3.2.8.3 Key Developments
- 3.2.8.4 Top Competitors
- 3.2.8.5 Key Personnel
- 3.2.8.6 Analyst View
- 3.2.9 Sterling Pharma Solutions
- 3.2.9.1 Overview
- 3.2.9.2 Top Products/Product/Service Portfolio
- 3.2.9.3 Key Developments
- 3.2.9.4 Top Competitors
- 3.2.9.5 Key Personnel
- 3.2.9.6 Analyst View
- 3.2.1 Almac Group
4 Research Methodology
- 4.1 Data Sources
- 4.1.1 Primary Data Sources
- 4.1.2 Secondary Data Sources
- 4.1.3 Data Triangulation
- 4.2 Market Estimation and Forecast
List of Figures
- Figure 1: Highly Potent API Market (by Region), $Billion, 2022-2033
- Figure 2: Highly Potent API Market, Recent Developments
- Figure 3: Highly Potent API Market: Value Chain Analysis
- Figure 4: Highly Potent API Market: Pricing Analysis
- Figure 5: Highly Potent API Market, Patent Analysis (by Year), January 2018-December 2023
- Figure 6: Highly Potent API Market, Patent Analysis (by Country), January 2018-December 2023
- Figure 7: Regulatory Framework for Highly Potent API
- Figure 8: Impact Analysis of Market Navigating Factors, 2022-2033
- Figure 9: Incidence of Cancer (by Region), Million, 2020-2040
- Figure 10: Europe Highly Potent API Market, $Billion, 2022-2033
- Figure 11: France Highly Potent API Market, $Billion, 2022-2033
- Figure 12: Germany Highly Potent API Market, $Billion, 2022-2033
- Figure 13: U.K. Highly Potent API Market, $Billion, 2022-2033
- Figure 14: Spain Highly Potent API Market, $Billion, 2022-2033
- Figure 15: Italy Highly Potent API Market, $Billion, 2022-2033
- Figure 16: Rest-of-Europe Highly Potent API Market, $Billion, 2022-2033
- Figure 17: Some of the Key Innovators in the Highly Potent API Landscape
- Figure 18: Highly Potent API Market: Geographical Assessment
- Figure 19: Strategic Initiatives, January 2021-December 2023
- Figure 20: Share of Strategic Initiatives
- Figure 21: Data Triangulation
- Figure 22: Top-Down and Bottom-Up Approach
- Figure 23: Assumptions and Limitations
List of Tables
- Table 1: Europe Highly Potent API Market Snapshot
- Table 2: Short-Term and Long-Term Opportunities and Risks (by Region)
- Table 3: Key Trends, Impact Analysis
- Table 4: Highly Potent API Market, Key Investment
- Table 5: Recent Innovations for Manufacturing and Handling of Highly Potent Drugs
- Table 6: Highly Potent API Market (by Region), $Billion, 2022-2033
- Table 7: Highly Potent API Market (by Country), $Billion, 2022-2033
